2160 — MicroPort CardioFlow Medtech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.24bn
- HK$915.67m
- CNY361.57m
- 28
- 32
- 70
- 38
Annual cashflow statement for MicroPort CardioFlow Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -398 | -183 | -451 | -464 | — |
| Depreciation | |||||
| Non-Cash Items | 249 | 24.4 | 170 | 178 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 15.3 | -47.7 | 20.6 | 5.27 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -110 | -162 | -183 | -207 | — |
| Capital Expenditures | -58.2 | -108 | -49.1 | -30.5 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.8 | -329 | -131 | -566 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -56.4 | -437 | -180 | -596 | — |
| Financing Cash Flow Items | -2.73 | -3.03 | 1.09 | -0.472 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 676 | 2,226 | -136 | -25.6 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 503 | 1,599 | -345 | -801 | — |